Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

U.S. Youth Vaping Rates Continue to Show Dramatic Decline

By Azim Chowdhury, Neelam Gill & Kaitlyn Johnson on September 19, 2024
Email this postTweet this postLike this postShare this post on LinkedIn

On September 5, 2024, the U.S Food and Drug Administration (“FDA”) and Centers for Diseases Control and Prevention (“CDC”) released data from the 2024 National Youth Tobacco Survey (“NYTS”), which shows the most remarkable decline in youth vaping to date. Specifically, the most recent NYTS, an annual, cross-sectional, web-based survey of U.S. middle school (grades 6-8) and high school (grades 9-12) students, indicates that the number of middle school (“MS”) and high school (“HS”) students reporting use of e-cigarettes or electronic nicotine delivery systems (“ENDS”) has declined to the lowest level in a decade. The 2024 NYTS was conducted among 29,861 HS and MS students from 283 schools between January 22 and May 22, 2024.   

NYTS Survey (Year)Percentage of High School Students Reporting Current E-Cigarette UseEstimated Weighted Number of High School Students Reporting Current E-Cigarette Use (Million)
20247.8%1.21
202310.0%1.56
202214.1%2.14
202111.3%1.72
202019.6%3.02
201927.5%4.11
  • The recent NYTS data show that the number of middle and high school students reporting current use of e-cigarettes in 2024 (1.63 million) constitutes only a fraction of the 2019 numbers (over 5 million – a large portion of which has been attributed to the rise of JUUL’s popularity at the time). See JUUL’s statement on the 2024 NYTS results here.
  • This trend has not slowed down in the past year, as the 2024 NYTS continues to demonstrate a downward trajectory for e-cigarettes. Significantly fewer middle school and high school students reported current e-cigarette use – from 2.13 million (7.7%) in 2023 to 1.63 million (5.9%) in 2024.
  • It is important to note that “current use” is defined by the NYTS to mean use on ≥1 day during the previous 30 days. In other words, a HS or MS student who vapes only once in the past month would be defined as a current user, regardless of their actual use or intention to use (or not use) the ENDS product in the future. Significantly, these numbers do not reflect daily use (i.e., use during all of the previous 30 days) or frequent use (as use on ≥20 days during the previous 30 days). In the NYTS publication, the authors include a disclaimer that these frequency of use estimates are not mutually exclusive. It is reasonable to assume that daily or frequent use would be a fraction of these “current use” numbers.
  • All in all, the data point to a continuing decline in youth use of the ENDS product category, given that half a million fewer youth are using e-cigarettes compared to last year’s data. FDA Center for Tobacco Products (“CTP”) Director Dr. Brian King described the “continued decline in e-cigarette use among our nation’s youth” as a “monumental public health win,” with an acknowledgment of the progress that has been made over the past half decade. 
  • Youth use of oral nicotine pouches was also highlighted in FDA’s press release, in which the Agency acknowledged that the numbers remained steady and low, with 1.5% of HS and MS students reporting current nicotine pouch use in 2023 and 1.8% in 2024. While the numbers are low, this comes with a caution that nearly half a million middle and high school students have still reported current nicotine pouch use. In fact, CDC makes it a point to state that, “[y]outh use of tobacco products in any form—including e-cigarettes and nicotine pouches—is unsafe,” quoting Deirdre Lawrence Kittner, Ph.D., M.P.H., director of CDC’s Office on Smoking and Health. This appears to be the first FDA NYTS news release that focuses its discussion of both e-cigarettes and nicotine pouches together as youth appealing tobacco products. In addition, FDA’s statement includes both a sub-title specifically addressing nicotine pouch results, as well as a dedicated paragraph on oral nicotine pouch numbers and brands used. Indeed, even the 2024 NYTS publication includes nicotine pouches in the publication title (“Notes from the Field: E-Cigarette and Nicotine Pouch Use Among Middle and High School Students — United States, 2024”).[1] All these factors suggest that pouches are top-of-mind for FDA when it comes to youth use.

We will discuss the potential impact of these data and enforcement trends and more at Keller and Heckman’s 2025 Annual E-Vapor and Tobacco Law Symposium on January 27-28, 2025, in Las Vegas, Nevada. Details and registration information can be found here.


[1] Park-Lee E, Jamal A, Cowan H, et al. Notes from the Field: E-Cigarette and Nicotine Pouch Use Among Middle and High School Students — United States, 2024. MMWR Morb Mortal Wkly Rep 2024;73:774–778. DOI: http://dx.doi.org/10.15585/mmwr.mm7335a3.

Photo of Azim Chowdhury Azim Chowdhury

Azim Chowdhury is a regulatory and public policy attorney with a focus on vapor, nicotine and tobacco product regulation. He is a Partner in Keller and Heckman’s nationally-ranked food and drug law practice.

Mr. Chowdhury advises domestic and foreign corporations in matters of…

Azim Chowdhury is a regulatory and public policy attorney with a focus on vapor, nicotine and tobacco product regulation. He is a Partner in Keller and Heckman’s nationally-ranked food and drug law practice.

Mr. Chowdhury advises domestic and foreign corporations in matters of Food and Drug Administration (FDA) and international regulatory compliance. In particular, he has developed expertise in tobacco and vapor product regulation relating to the implementation of the Family Smoking Prevention and Tobacco Control Act, and spearheaded the Tobacco and E-Vapor practice at Keller and Heckman. Specifically, Mr. Chowdhury has experience representing tobacco, e-cigarette and e-liquid manufacturers, distributors, retailers, suppliers and trade associations in matters of FDA, state and global regulatory compliance. He also assists corporations in establishing clearances for food and drug additives in the U.S., Canada, and European Union, with an emphasis on indirect additives used in food-contact materials.

Mr. Chowdhury has authored and edited numerous articles and publications, including Tobacco Regulation and Compliance: An Essential Resource, FDA Regulation of Tobacco: A Comprehensive Guide – An FDLI Primer and Tobacco and Nicotine Delivery: Regulation and Compliance, 2nd Edition. He is a frequent contributor to the Food and Drug Law Institute’s (FDLI) Update Magazine and has served on the Editorial Advisory Board of the Food and Drug Law Journal.  In addition, he has been interviewed in the U.S. News and World Reports Best Lawyers Edition (2016) and was named one of “10 Names to Know in the Vape World” in the October 2015 issue of Vape Magazine. Mr. Chowdhury received the 2018 National Law Review Go-To Thought Leadership Award for his consistent coverage of the emerging issues surrounding vaping and e-cigarettes on Keller and Heckman’s law blog, The Continuum of Risk.  As an industry leader, Mr. Chowdhury frequently speaks at industry conferences and events.

Mr. Chowdhury also has an active pro bono practice through Keller and Heckman’s Pro Bono Program, and has been featured in the Baltimore Sun for successfully obtaining asylum in the United States for a family who fled their home country of El Salvador because of violence they faced from an international gang.

Prior to entering private practice, he served as a judicial law clerk on the Court of Special Appeals of Maryland. Mr. Chowdhury received a B.A. and B.S. from Johns Hopkins University, a MBA from the University of Maryland Robert H. Smith School of Business, and a JD, cum laude, from the University of Maryland School of Law.

Education: Johns Hopkins University (B.A., B.S., 2003); University of Maryland Robert H. Smith School of Business (M.B.A., 2006); University of Maryland School of Law (J.D., 2006, cum laude).

Admissions: District of Columbia; Maryland

Read more about Azim ChowdhuryEmailAzim's Linkedin ProfileAzim's Twitter Profile
Show more Show less
Photo of Neelam Gill Neelam Gill
Read more about Neelam GillEmailNeelam's Linkedin Profile
Photo of Kaitlyn Johnson Kaitlyn Johnson
Email
  • Posted in:
    Food, Drug & Agriculture
  • Blog:
    The Continuum of Risk
  • Organization:
    Keller Heckman
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo